GENERIC BRAND CLASSIFICATION ACTUAL MECHANISM INDICATION CONTRAINDICATION ADVERSE NURSING RESPONSIBILITIES

NAME NAME DOSAGE OF ACTION EFECT

Meperidine Demerol Opiate analgesic 25mg IV now Binds to opioid Acts as an Use of MAOIs within Overdose • Verify
receptors within agonist at 14 days results in: any medication order and
CNS and alters specific opioid -respiratory make sure it's complete.
pain perception, receptors in the depression • Check the patient's medical
emotional central nervous -skeletal record for an allergy or
response to pain. system (CNS) to muscle contraindication to the
produce flaccidity prescribed medication.
analgesia, -cold/ clammy • Prepare medications for
euphoria, and skin one patient at a time.
sedation -cyanosis • Educate patients about
- extreme their medications.
drowsiness • Follow the eight rights
-seizures of medication administratio
-stupor n.
-coma. • Give the opioid drug at
least 30-60 minutes prior to
activities or painful
procedures.
• Obtain vital signs before
administering medication
especially blood pressure
and respiration.
• Patient should be in a
recumbent position before
drug is administered by
parenteral route.
• Assess onset, type,
location, and duration of
pain prior to administering
medication.
 • Change positions slowly to
avoid orthostatic
hypotension.
• Increase fluid intake to
prevent constipation.
• Teach patient to avoid
alcohol and other CNS
depressants while taking
the medication.
• Avoid tasks requiring
mental alertness and motor
skills until response to drug
is established.

GENERIC BRAN CLASSIFIC ACTUAL MECHANISM INDICATION CONTRAINDIC ADVERSE NURSING RESPONSIBILITIES
NAME D ATION DOSAGE OF ACTION ATION EFECT
NAME

Progesterone Prome Hormone; PO: 4 times  Inhibition  Treatment History of or Thrombo- -Assess for possibility of pregnancy or hypersensitivity to
trium Progestin a day for the of follicular for: suspected phlebitis progestins before initiating therapy.
next 5 days development,  Amenorrhea carcinoma of -cerebro- - Obtain baseline weight, serum glucose level, B/P.
or until ovulation, and  Abnormal breast, active vascular - Obtain medical health history.
bleeding corpusluteum uterine bleeding breast cancer, disorders - Check weight daily and report weekly gain over 5 lbs.
stops and formation.  Prevention history of -retinal -Assess skin for rash, urticaria.
once a day  Decrease of Endometrial thromboemboli thrombosis -Facilitate importance of immediately reporting
when the s abnormal Hyperplasia c disorders, -pulmonary development of chest pain, sudden shortness of breath,
bleeding uterine  Infertility history of embolism sudden decrease in vision, migraine headache, pain (esp.
stops for the bleeding; thrombophlebiti with swelling, warmth, redness) in calves, numbness of
rest of the transforms s, missed arm/leg (thrombotic disorders).
cycle until 3 endometrium abortion or -Check B/P periodically.
months from ectopic - Instruct the patient to notify physician regarding
proliferative pregnancy, abnormal vaginal bleeding and other symptoms.
to secretory in severe hepatic -Instruct the patient to stop taking medication, contact
estrogen- dysfunction, physician at once if pregnancy is suspected.
primed undiagnosed - Emphasize the need to avoid smoking. Cigarette
endometrium abnormal smoking increases the risk of serious cardiovascular
vaginal events from oral contraceptive use.
bleeding, use as - Educate the patient to have a yearly visit with the
a pregnancy healthcare provider for a blood pressure check and for
test. other indicated healthcare.
-Facilitate instruction for safety that when getting out of
bed, rest feet on the floor for a few minutes before
standing up to avoid dizziness, lightheadedness, and
fainting when getting up too quickly from a lying position.
- Instruct to avoid driving a car or operating machinery
until response to medication is established. If progesterone
does make her dizzy or drowsy, take the daily dose at
bedtime.
- Emphasize the importance of avoidance of anyone else
taking the medication.
- Inform that the potential adverse effects of long-term use
of progestin with estrogen include invasive breast cancer,
heart disease-related events, dementia (including
Alzheimer's disease), stroke and blood clots.
 GENERIC BRAND CLASSIFI ACTUAL MECHANISM INDICATION CONTRAINDIC ADVERSE EFECT NURSING RESPONSIBILITIES
NAME NAME CATION DOSAGE OF ACTION ATION

Lactated Lactated Hyperto 1L of D5LR Hypertonic Indicated as a Hypersensitivit febrile response • Assess health history. Patients with kidney
ringer's and Ringer's nic- over 4 hours solutions have an source of water, y to any of the -infection at the site or heart disease and those who are
5% dextrose in 5% Nonpyro effective electrolytes and components of injection dehydrated should not receive hypertonic
injection Dextrose genic, osmolarity calories or as an -Renal failure -venous thrombosis IV fluids.
parenter greater than the alkalinizing agent. -Liver or phlebitis • Document baseline vital signs, edema, lung
al body fluids. This dysfunction extending from the sounds, and heart sounds and continue
fluid,ele will pull the - Diabetes site of injection monitoring after infusion.
ctrolyte fluid into the Mellitus -extravasation •  Do not administer unless solution is clear
and vascular by -Lactic acidosis -hypervolemia. and container is undamaged. 
nutrient osmosis, -Alkalosis -localized or • Dont give concentrated solutions IM or
replenish resulting in an -Hyperkalemia generalized urticaria subcutaneously .
er increase vascular and pruritis • Check vital signs frequently.
volume. It raises -periorbital, facial, • Solution containing acetate should be used
intravascular and/or laryngeal with caution as excess administration may
osmotic pressure edema result in metabolic alkalosis
and therefore -coughing • Solution containing dextrose should be
provides fluid, -sneezing used with caution in px with known
electrolytes and -difficulty with subclinical or overt diabetes mellitus.
calories for breathing • Label the IV fluid properly.
energy. • Observe aseptic terchnique when changing
IV fluid.
• Observe IV site at least every hour for
complications such as infiltration, phlebitis,
infection, air embolism and fluid overload.
Monitor infusion rate.
 GENERIC BRAND CLASSIFICATION ACTUAL MECHANISM OF INDICATION CONTRAINDICATION ADVERSE NURSING RESPONSIBILITIES
NAME NAME DOSAGE ACTION EFECT

Aspiri Bayer Nonsteroidal 2.4g to • Inhibits Treatment of Hyper-sensitivity to High doses may • Assess type, location, duration
n salicylate. Anti- 3.6g/day in prostaglandin mild to salicylates, NSAIDs; result in: of pain, inflammation.
inflammatory, divided synthesis moderate pain, asthma, rhinitis, nasal -GI bleeding • - Assess skin for evidence of
 antipyretic, dose • acts on the fever. polyps; inherited or and/or gastric ecchymosis.
anticoagulant hypothalamus acquired bleeding mucosal lesions • - Instruct the patient to avoid
heat-regulating disorders -Reye’s crushing or chewing enteric-
center syndrome coated tablets.
• interferes -tinnitus • - Instruct the patient not to use,
with production -generalized if vinegarlike odor is noted
of thromboxane pruritus which indicates chemical
A, a substance -headache breakdown.
that stimulates -dizziness • -Instruct the patient no to take
platelet -flushing aspirin if experiencing bleeding.
aggregation. -tachycardia • - Instruct the patient to take
- aspirin with a full glass of water
hyperventilation with meals or after meals to
-diaphoresis prevent stomach upset.
- thirst • -Monitor urinary pH (sudden
-hyperthermia acidification, pH from 6.5 to
-restlessness 5.5, may result in toxicity).
-seizures • -If given as antipyretic, assess
-abnormal temperature directly before and
breathing 1 hr after giving medication.
patterns • - Evaluate for therapeutic
- respiratory response: relief of pain,
failure stiffness, swelling; increased
- coma. joint mobility; reduced joint
tenderness; improved grip
strength.
• -Educate the patient to avoid
alcohol.
• -Instruct the patient to report
tinnitus or persistent abdominal
GI pain, bleeding to the
physician immediately.